[go: up one dir, main page]

MA27867A1 - Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif. - Google Patents

Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.

Info

Publication number
MA27867A1
MA27867A1 MA27487A MA27487A MA27867A1 MA 27867 A1 MA27867 A1 MA 27867A1 MA 27487 A MA27487 A MA 27487A MA 27487 A MA27487 A MA 27487A MA 27867 A1 MA27867 A1 MA 27867A1
Authority
MA
Morocco
Prior art keywords
derivatives
pyridazine
novel
preparing
active ingredient
Prior art date
Application number
MA27487A
Other languages
English (en)
Inventor
Jozsef Barkoczy
Nagy Peter Kotay
Gyula Simig
Gyorgy Levay
Istvan Gacsalyi
Andras Egyed
Bajnogel Judit Raczne
Katalin Pallagi
Eva Schmidt
Gabor Szenasi
Kovacs Aniko Miklosne
Janos Wellmann
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of MA27867A1 publication Critical patent/MA27867A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention réfère plus particulièrement aux nouveaux dérivés 2H-pyridazine-3- de la formule.
MA27487A 2001-07-26 2004-01-19 Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif. MA27867A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0103063A HU225955B1 (en) 2001-07-26 2001-07-26 Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
MA27867A1 true MA27867A1 (fr) 2006-05-02

Family

ID=89979562

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27487A MA27867A1 (fr) 2001-07-26 2004-01-19 Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.

Country Status (27)

Country Link
US (1) US7098210B2 (fr)
EP (1) EP1417206B1 (fr)
JP (1) JP4249012B2 (fr)
KR (1) KR100909514B1 (fr)
CN (1) CN1247571C (fr)
AR (2) AR036248A1 (fr)
AT (1) ATE466859T1 (fr)
AU (1) AU2002321669B8 (fr)
BR (1) BR0211440A (fr)
CA (1) CA2453917C (fr)
CY (1) CY1110240T1 (fr)
CZ (1) CZ2004123A3 (fr)
DE (1) DE60236294D1 (fr)
DK (1) DK1417206T3 (fr)
EA (1) EA006246B1 (fr)
ES (1) ES2345541T3 (fr)
HU (1) HU225955B1 (fr)
MA (1) MA27867A1 (fr)
MX (1) MXPA04000814A (fr)
NO (1) NO326155B1 (fr)
NZ (1) NZ531154A (fr)
PL (1) PL206824B1 (fr)
PT (1) PT1417206E (fr)
SI (1) SI1417206T1 (fr)
SK (1) SK552004A3 (fr)
WO (1) WO2003010166A1 (fr)
ZA (1) ZA200400482B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227255B1 (en) 2002-04-26 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Novel piperidine-alkyl-amino-pyridazine derivatives, pharmaceutical compositions containing the same and process for the preparation of the active ingredient
CN102663977B (zh) 2005-06-08 2015-11-18 伊格尼斯创新有限公司 用于驱动发光器件显示器的方法和系统
US9489891B2 (en) 2006-01-09 2016-11-08 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
US9269322B2 (en) 2006-01-09 2016-02-23 Ignis Innovation Inc. Method and system for driving an active matrix display circuit
CA2570898C (fr) 2006-01-09 2008-08-05 Ignis Innovation Inc. Methode et systeme d'alimentation d'un circuit actif a affichage matriciel
HUP0600555A3 (en) * 2006-07-03 2008-10-28 Egis Gyogyszergyar Nyrt Use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]izoxazol-3-yl)piperidin-1-yl]ethylamino}2-methyl-3(2h)-piridazinon for the production of pharmaceutical compositions for influencing cognitive functions and causing neuroprotective effect
CN104299566B (zh) 2008-04-18 2017-11-10 伊格尼斯创新公司 用于发光器件显示器的系统和驱动方法
CA2637343A1 (fr) 2008-07-29 2010-01-29 Ignis Innovation Inc. Amelioration de pilote de source d'affichage
US9370075B2 (en) 2008-12-09 2016-06-14 Ignis Innovation Inc. System and method for fast compensation programming of pixels in a display
US8283967B2 (en) 2009-11-12 2012-10-09 Ignis Innovation Inc. Stable current source for system integration to display substrate
CA2687631A1 (fr) 2009-12-06 2011-06-06 Ignis Innovation Inc Mecanisme de commande a faible puissance pour applications d'affichage
CA2696778A1 (fr) 2010-03-17 2011-09-17 Ignis Innovation Inc. Procedes d'extraction des parametres d'uniformite de duree de vie
US20140368491A1 (en) 2013-03-08 2014-12-18 Ignis Innovation Inc. Pixel circuits for amoled displays
US9886899B2 (en) 2011-05-17 2018-02-06 Ignis Innovation Inc. Pixel Circuits for AMOLED displays
US9351368B2 (en) 2013-03-08 2016-05-24 Ignis Innovation Inc. Pixel circuits for AMOLED displays
EP2945147B1 (fr) 2011-05-28 2018-08-01 Ignis Innovation Inc. Procédé de programmation de compensation rapide de pixels dans un affichage
US9747834B2 (en) 2012-05-11 2017-08-29 Ignis Innovation Inc. Pixel circuits including feedback capacitors and reset capacitors, and display systems therefore
US9786223B2 (en) 2012-12-11 2017-10-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
US9336717B2 (en) 2012-12-11 2016-05-10 Ignis Innovation Inc. Pixel circuits for AMOLED displays
WO2014124755A1 (fr) 2013-02-18 2014-08-21 Jürgen Von Der Ohe Procédé et dispositif de nettoyage au jet froid
US9721505B2 (en) 2013-03-08 2017-08-01 Ignis Innovation Inc. Pixel circuits for AMOLED displays
CA2894717A1 (fr) 2015-06-19 2016-12-19 Ignis Innovation Inc. Caracterisation d'un dispositif optoelectronique au moyen d'une ligne de sens partage
CA2873476A1 (fr) 2014-12-08 2016-06-08 Ignis Innovation Inc. Architecture d'affichage de pixels intelligents
CA2886862A1 (fr) 2015-04-01 2016-10-01 Ignis Innovation Inc. Ajustement de la luminosite d'affichage en vue d'eviter la surchauffe ou le vieillissement accelere
US10373554B2 (en) 2015-07-24 2019-08-06 Ignis Innovation Inc. Pixels and reference circuits and timing techniques
CA2898282A1 (fr) 2015-07-24 2017-01-24 Ignis Innovation Inc. Etalonnage hybride de sources de courant destine a des afficheurs a tension polarisee par courant programmes
US10657895B2 (en) 2015-07-24 2020-05-19 Ignis Innovation Inc. Pixels and reference circuits and timing techniques
CA2908285A1 (fr) 2015-10-14 2017-04-14 Ignis Innovation Inc. Pilote comportant une structure de pixel a plusieurs couleurs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
IL117646A (en) * 1995-04-12 2000-06-01 Ferrer Int 7-¬3-¬4-(6-fluoro-1,2-benzisoxazole-3-YL)piperidin-1-YL¾propoxy¾3-alkyl-chromen-4-ones their preparation their uses and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
KR20040030862A (ko) 2004-04-09
CY1110240T1 (el) 2015-01-14
CA2453917A1 (fr) 2003-02-06
ZA200400482B (en) 2005-05-25
US7098210B2 (en) 2006-08-29
ES2345541T3 (es) 2010-09-27
HK1067626A1 (en) 2005-04-15
SK552004A3 (en) 2004-08-03
ATE466859T1 (de) 2010-05-15
US20040171619A1 (en) 2004-09-02
HUP0103063A2 (hu) 2003-02-28
HU225955B1 (en) 2008-01-28
AR036248A1 (es) 2004-08-25
PL367447A1 (en) 2005-02-21
EP1417206B1 (fr) 2010-05-05
PT1417206E (pt) 2010-07-29
JP2004538293A (ja) 2004-12-24
CA2453917C (fr) 2009-06-23
BR0211440A (pt) 2004-07-20
EA006246B1 (ru) 2005-10-27
MXPA04000814A (es) 2004-05-21
CN1247571C (zh) 2006-03-29
NO20040268L (no) 2004-03-23
AR088808A2 (es) 2014-07-10
EA200400223A1 (ru) 2004-12-30
NO326155B1 (no) 2008-10-13
DE60236294D1 (de) 2010-06-17
CN1545513A (zh) 2004-11-10
AU2002321669A2 (en) 2003-02-17
HUP0103063A3 (en) 2005-06-28
SI1417206T1 (sl) 2010-09-30
EP1417206A1 (fr) 2004-05-12
JP4249012B2 (ja) 2009-04-02
KR100909514B1 (ko) 2009-07-27
AU2002321669B8 (en) 2008-06-05
HU0103063D0 (en) 2001-10-28
AU2002321669B2 (en) 2008-05-15
WO2003010166A1 (fr) 2003-02-06
DK1417206T3 (da) 2010-08-16
NZ531154A (en) 2005-09-30
CZ2004123A3 (cs) 2004-05-12
PL206824B1 (pl) 2010-09-30

Similar Documents

Publication Publication Date Title
MA27867A1 (fr) Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
MA27559A1 (fr) Nouveaux derives de fluorglycoside aromatiques, produits pharmaceutiques contenant ces composes et leur utilisation
FR2805817B1 (fr) Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
MA27560A1 (fr) Nouveaux derives de fluorglycoside heterocycliques, produits pharmaceutiques contenant ces composes et leur utilisation
BR9908545A (pt) Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
MA27093A1 (fr) Derives de sulfonamides, leur preparation et leur application comme medicaments.
ATE402929T1 (de) Pyrazinverbindungen als inhibitoren des transforming growth factor (tgf)
MA27769A1 (fr) Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique
TNSN06439A1 (fr) Derives de 2-carbamide -4-phenylthiazole, leur preparation et leur application en therapeutique
MA29926B1 (fr) Derives de pyrazine
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
MA28747B1 (fr) Dérivés de pyridine
TN2009000428A1 (fr) Derives de sulfonylamides destines au traitement d'une croissance cellulaire anormale
MA27389A1 (fr) Derives de benzimidazole nouveaux utiles comme agents antiproliferatifs.
SE9903894D0 (sv) Novel compounds
EP1725536B8 (fr) Derives de l'imidazoline presentant une activite antagoniste cb1
SE9804212D0 (sv) Compounds
TNSN00250A1 (fr) Composes nouveaux inhibiteurs de pcp, procede pour leur preparation et compositions les contenant
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
DE60139409D1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
MA28286A1 (fr) Dérivés de 1-N-phenyl-amino-1H-imidazole et compositions pharmaceutiques les contenant
DE60119514D1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure